Re: Times frames FDA/BP/RVX deal
|
5
|
Resverlogix Corp.
|
Jun 11, 2020 02:03PM
|
Re: thinking a partner will come this year
|
|
Resverlogix Corp.
|
Jun 10, 2020 12:14PM
|
Re: It's showtime!!
|
3
|
Resverlogix Corp.
|
Jun 10, 2020 08:51AM
|
Re: Convertible Debenture
|
3
|
Zenith Epigenetics
|
May 30, 2020 12:07PM
|
Re: Breakthrough Designation
|
5
|
Resverlogix Corp.
|
May 28, 2020 05:34PM
|
Re: Breakthrough Designation
|
3
|
Resverlogix Corp.
|
May 28, 2020 02:36PM
|
Re: Breakthrough Designation
|
1
|
Resverlogix Corp.
|
May 28, 2020 01:47PM
|
Re: Breakthrough Designation
|
2
|
Resverlogix Corp.
|
May 28, 2020 01:00PM
|
Re: Breakthrough Designation
|
5
|
Resverlogix Corp.
|
May 28, 2020 12:28PM
|
ZENI-P listing
|
7
|
Zenith Epigenetics
|
May 25, 2020 04:30PM
|
Re: Nature Article on the role of Endothelial Cells in COVID 19
|
5
|
Resverlogix Corp.
|
May 24, 2020 02:12PM
|
Re: Zenith Capital Corporation symbol
|
3
|
Zenith Epigenetics
|
May 22, 2020 12:02PM
|
Re: Zenith Capital Corporation symbol
|
1
|
Zenith Epigenetics
|
May 21, 2020 10:14PM
|
Re: Zenith Capital Corporation symbol
|
6
|
Zenith Epigenetics
|
May 21, 2020 12:36PM
|
Convertible Debenture
|
5
|
Zenith Epigenetics
|
May 15, 2020 01:34PM
|
Re: Report of exempt distribution
|
3
|
Resverlogix Corp.
|
May 07, 2020 02:38PM
|
Re: RVXOT
|
1
|
Zenith Epigenetics
|
May 06, 2020 02:32PM
|
Re: RVXOT
|
1
|
Zenith Epigenetics
|
May 06, 2020 11:59AM
|
Re: Lots of new options and deferred share units issued on Friday
|
3
|
Resverlogix Corp.
|
May 06, 2020 11:19AM
|
Re: RVXOT
|
1
|
Zenith Epigenetics
|
May 06, 2020 11:02AM
|